These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 137841)

  • 21. [A case of acute leukemia associated with Down's syndrome showing myeloid and lymphoid markers (author's transl)].
    Muchi H; Ohira M; Ise T; Shimoyama M; Minato K; Saito H; Watanabe S
    Rinsho Ketsueki; 1980 Mar; 21(3):388-95. PubMed ID: 6447814
    [No Abstract]   [Full Text] [Related]  

  • 22. [Specific cellular immunity indices in acute leukemia in children].
    Osipov SG; Bergol'ts VM; Eremeev VS; Akimova GV; Rumiantsev AG
    Vopr Onkol; 1981; 27(1):20-2. PubMed ID: 7456440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukaemia antigens: mixed leucocyte culture tests on twelve leukaemic patients with identical twins.
    Fefer A; Mickelson E; Thomas ED
    Clin Exp Immunol; 1974 Oct; 18(2):237-42. PubMed ID: 4283118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies to CD18 and CD11A (LFA-1) distinguish Down's syndrome (trisomy 21) from normal lymphoblastoid cells.
    Robson AJ; Taylor GM; D'Souza SW
    Dis Markers; 1989; 7(3):169-80. PubMed ID: 2569955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Australia antigen in Down's syndrome patients with Robertsonian translocation.
    Tevaluoto-Aarnio M; Hongell K
    Med Biol; 1974 Feb; 52(1):70-1. PubMed ID: 4283654
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to leukemia: immunologic factors in Down's syndrome.
    Sutnick AI; London WT; Blumberg BS; Gerstley BJ
    J Natl Cancer Inst; 1971 Nov; 47(5):923-33. PubMed ID: 4256452
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lymphocyte migration inhibition reaction indices using myocardial cell membrane antigens in children with rheumatism].
    Borisova AM; Kuz'mina NN; Karpocheva MP
    Vopr Revm; 1980; (1):13-6. PubMed ID: 7385743
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of leucocyte migration by antigens from human colon and E. coli O 14 in patients with ulcerative colitis.
    Fixa B; Komárová O; Skaunic V; Nerad M; Kojecký Z; Benỳŝek L
    Scand J Gastroenterol; 1975; 10(5):491-3. PubMed ID: 1098133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antigenic treatment of patients with Down's syndrome].
    Ruiz-Castañeda M; Gutiérrez de Velásco-Hernández C; Gómez-Ortiz ME; Pillado-Hernández MT
    Bol Med Hosp Infant Mex; 1982 Dec; 39(12):778-80. PubMed ID: 6220726
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymic deficiency in Down's syndrome.
    Levin S; Schlesinger M; Handzel Z; Hahn T; Altman Y; Czernobilsky B; Boss J
    Pediatrics; 1979 Jan; 63(1):80-7. PubMed ID: 155804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of correlation between inhibitory or stimulatory influence of kidney antigens on in vitro leukocyte and lymphocyte migration in renal-transplanted patients.
    Skopińska-Rózewska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):499-504. PubMed ID: 7036935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte function and serum immunoglobulins in Down's syndrome.
    Rosner F; Kozinn PJ; Jervis GA
    N Y State J Med; 1973 Mar; 73(5):672-5. PubMed ID: 4265822
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease.
    Marcussen H; Bendixen G
    Scand J Gastroenterol; 1974; 9(2):149-52. PubMed ID: 4206480
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of leucocyte migration inhibition test in coeliac disease. A reassessment using different gluten subfractions.
    Corazza GR; Rawcliffe PM; Frisoni M; Sarchielli P; Londei M; Campieri M; Lazzari R; Gasbarrini G
    Clin Exp Immunol; 1985 Apr; 60(1):117-22. PubMed ID: 4006297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early and late allergic reactions in cases of Down's syndrome in children].
    Romański B; Walczyński Z
    Pediatr Pol; 1966 Oct; 41(10):1163-6. PubMed ID: 4227136
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM; Mick R; Johnson FL
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of hepatitis B surface antigen in patients with Down's syndrome.
    Yüksel M; Uzunalimoğlu O; Oge G; Demirağ B
    Turk J Pediatr; 1977; 19(1-2):47-51. PubMed ID: 154756
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.